Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Women's interest in gene expression analysis for breast cancer recurrence risk.

O'Neill SC, Brewer NT, Lillie SE, Morrill EF, Dees EC, Carey LA, Rimer BK.

J Clin Oncol. 2007 Oct 10;25(29):4628-34.

PMID:
17925559
2.

Uptake rates for breast cancer genetic testing: a systematic review.

Ropka ME, Wenzel J, Phillips EK, Siadaty M, Philbrick JT.

Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):840-55. Review.

3.

Use of the Oncotype DX 21-gene assay to guide adjuvant decision making in early-stage breast cancer.

Conlin AK, Seidman AD.

Mol Diagn Ther. 2007;11(6):355-60. Review.

PMID:
18078353
4.

"Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.

Glinsky GV.

J Clin Oncol. 2008 Jun 10;26(17):2846-53. doi: 10.1200/JCO.2008.17.0266. Review.

PMID:
18539963
5.

Gene-expression assays: new tools to individualize treatment of early-stage breast cancer.

Dobbe E, Gurney K, Kiekow S, Lafferty JS, Kolesar JM.

Am J Health Syst Pharm. 2008 Jan 1;65(1):23-8. Review.

PMID:
18159035
6.

Genetic testing and pharmacogenomics: issues for determining the impact to healthcare delivery and costs.

Phillips KA, Veenstra DL, Ramsey SD, Van Bebber SL, Sakowski J.

Am J Manag Care. 2004 Jul;10(7 Pt 1):425-32. Review.

7.

Genomic predictors of outcome and treatment response in breast cancer.

Dunn L, Demichele A.

Mol Diagn Ther. 2009;13(2):73-90. doi: 10.2165/01250444-200913020-00002. Review.

PMID:
19537843
8.

Interactive patient decision aids for women facing genetic testing for familial breast cancer: a systematic web and literature review.

Williams L, Jones W, Elwyn G, Edwards A.

J Eval Clin Pract. 2008 Feb;14(1):70-4. doi: 10.1111/j.1365-2753.2007.00798.x. Review.

PMID:
18211647
9.

New molecular classifications of breast cancer.

Cianfrocca M, Gradishar W.

CA Cancer J Clin. 2009 Sep-Oct;59(5):303-13. doi: 10.3322/caac.20029. Review.

10.

The fertility-related concerns, needs and preferences of younger women with breast cancer: a systematic review.

Peate M, Meiser B, Hickey M, Friedlander M.

Breast Cancer Res Treat. 2009 Jul;116(2):215-23. doi: 10.1007/s10549-009-0401-6. Epub 2009 Apr 24. Review.

PMID:
19390962
11.

Systematic review: gene expression profiling assays in early-stage breast cancer.

Marchionni L, Wilson RF, Wolff AC, Marinopoulos S, Parmigiani G, Bass EB, Goodman SN.

Ann Intern Med. 2008 Mar 4;148(5):358-69. Epub 2008 Feb 4. Review.

PMID:
18252678
12.

Experiences and attitudes toward risk of recurrence testing in women with breast cancer: a systematic review.

Leggett LE, Lorenzetti DL, Noseworthy T, Tiwana S, Mackean G, Clement F.

Breast Cancer Res Treat. 2014 Apr;144(3):457-65. doi: 10.1007/s10549-014-2900-3. Epub 2014 Mar 5. Review.

PMID:
24596049
13.

Individualizing therapeutic decision making in early-stage breast cancer.

Oestreicher P.

ONS Connect. 2007;22(8 Suppl):41-2. Review. No abstract available.

PMID:
17824559
14.

Attitudes towards predictive genetic testing in minors for familial breast cancer: a systematic review.

Borry P, Stultiƫns L, Nys H, Dierickx K.

Crit Rev Oncol Hematol. 2007 Dec;64(3):173-81. Epub 2007 Jun 5. Review.

PMID:
17553690
15.

Direct-to-consumer genomic testing: systematic review of the literature on user perspectives.

Goldsmith L, Jackson L, O'Connor A, Skirton H.

Eur J Hum Genet. 2012 Aug;20(8):811-6. doi: 10.1038/ejhg.2012.18. Epub 2012 Feb 15. Review.

Supplemental Content

Support Center